Active	Status	Sponsor type	Region	Phase	Filter
6 Active 4 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
George, Jacob
B-Well 2, NCT05630820 / 2022-002268-53: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B	Active, not recruiting	3	871	Europe, Canada, Japan, US, RoW	Bepirovirsen, Placebo	GlaxoSmithKline, GlaxoSmithKline Research & Development Limited	Chronic Hepatitis B, Hepatitis B, Chronic	11/25	05/26
B-UNITED, NCT06537414: A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)	Recruiting	2	280	Europe, Canada, Japan, US, RoW	Daplusiran/Tomligisiran Dose Level 1, Daplusiran/Tomligisiran Dose Level 2, Bepirovirsen, Placebo	GlaxoSmithKline	Chronic Hepatitis B Virus Infection, Hepatitis B	10/27	10/27
HBVPOCT, NCT05144776: Evaluation of Hepatitis B Virus (HBV) DNA Test as Point of Care Tool	Recruiting	N/A	300	RoW	GeneXpert HBV DNA Viral Load Assay, Dried Blood Spot HBV DNA test	Kirby Institute	Hepatitis B	12/24	12/25
NCT05042544: The National Australian HCV Point-of-Care Testing Program	Recruiting	N/A	40000	RoW	Point-of-Care Testing	Kirby Institute, Flinders University	Hepatitis C	12/24	12/26
REACH-B, NCT04914611: Real World Assessment of People Living With Chronic Hepatitis B in Australia	Recruiting	N/A	10000	RoW	No intervention	Kirby Institute	Hepatitis B	07/26	07/27
NCT04455932: HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation	Recruiting	N/A	476	RoW	Abbreviated non-contrast MRI of the liver, aNC-MRI, Ultrasound surveillance, US surveillance, Multiphase contrast-enhanced liver MRI, Multiphase liver MRI	Concord Repatriation General Hospital	Hepatocellular Carcinoma, HCC	12/26	03/27